{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T07:37:53Z","timestamp":1763105873873,"version":"3.41.2"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Complement factor H-related 4 (CFHR4) is a protein-coding gene that plays an essential role in multiple diseases. However, the prognostic value of CFHR4 in hepatocellular carcinoma (HCC) is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using multiple databases, we investigated CFHR4 expression levels in HCC and multiple cancers. The relationship between CFHR4 expression levels and clinicopathological variables was further analyzed. Various potential biological functions and regulatory pathways of CFHR4 in HCC were identified by performing a Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Gene Set Enrichment Analysis (GSEA). Single-sample gene set enrichment analysis (ssGSEA) was performed to confirm the correlation between CFHR4 expression and immune cell infiltration. The correlations between CFHR4 expression levels in HCC and N6-methyladenosine (m6A) modifications and the competing endogenous RNA (ceRNA) regulatory networks were confirmed in TCGA cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CFHR4 expression levels were significantly decreased in HCC tissues. Low CFHR4 expression in HCC tissues was significantly correlated with the patients\u2019 sex, race, age, TNM stage, pathological stage, tumor status, residual tumor, histologic grade and alpha fetal protein (AFP) level. GO and KEGG analyses revealed that differentially expressed genes related to CFHR4 may be involved in the synaptic membrane, transmembrane transporter complex, gated channel activity, chemical carcinogenesis, retinol metabolism, calcium signaling pathway, PPAR signaling pathway, insulin and gastric acid secretion. GSEA revealed that the FCGR-activated reaction, PLK1 pathway, ATR pathway, MCM pathway, cascade reactions of PI3K and FGFR1, reactant-mediated MAPK activation and FOXM1 pathway were significantly enriched in HCC with low CFHR4 expression. Moreover, CFHR4 expression was inversely correlated the levels of infiltrating Th2 cells, NK CD56bright cells and Tfh cells. In contrast, we observed positive correlations with the levels of infiltrating DCs, neutrophils, Th17 cells and mast cells. CFHR4 expression showed a strong correlation with various immunomarker groups in HCC. In addition, high CFHR4 expression significantly prolonged the overall survival (OS), disease-specific survival (DSS) and progression-free interval (PFI). We observed a substantial correlation between the expression of CFHR4 and multiple N6-methyladenosine genes in HCC and constructed potential CFHR4-related ceRNA regulatory networks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>CFHR4 might be a potential therapeutic target for improving the HCC prognosis and is closely related to immune cell infiltration.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.892750","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T05:56:34Z","timestamp":1655877394000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Hongjun","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanjia","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoyu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shounan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baolin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongliang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangha","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer Statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular Carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and Surveillance for Hepatocellular Carcinoma: New Trends","volume":"72","author":"Singal","year":"2020","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.11.035","article-title":"The PGC1alpha\/NRF1-MPC1 Axis Suppresses Tumor Progression and Enhances the Sensitivity to Sorafenib\/Doxorubicin Treatment in Hepatocellular Carcinoma","volume":"163","author":"Wang","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nri.2017.97","article-title":"Complement in Cancer: Untangling an Intricate Relationship","volume":"18","author":"Reis","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.689435","article-title":"Modulation of the Complement System by Neoplastic Disease of the Central Nervous System","volume":"12","author":"Yarmoska","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660194","article-title":"A Family Affair: Addressing the Challenges of Factor H and the Related Proteins","volume":"12","author":"Poppelaars","year":"2021","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement Factor H Related Proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.12.023","article-title":"Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated With Systemic Complement Activation: Implications in Age-Related Macular Degeneration","volume":"125","author":"Lores-Motta","year":"2018","journal-title":"Ophthalmology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41467-020-14499-3","article-title":"Increased Circulating Levels of Factor H-Related Protein 4 Are Strongly Associated With Age-Related Macular Degeneration","volume":"11","author":"Cipriani","year":"2020","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1002079","DOI":"10.1371\/journal.pgen.1002079","article-title":"Association of Genetic Variants in Complement Factor H and Factor H-Related Genes With Systemic Lupus Erythematosus Susceptibility","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019050515","article-title":"CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy","volume":"31","author":"Zipfel","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of Factor H Autoantibodies With Deletions of CFHR1, CFHR3, CFHR4, and With Mutations in CFH, CFI, CD46, and C3 in Patients With Atypical Hemolytic Uremic Syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.540186","article-title":"Gene Signatures and Prognostic Values of M6a Regulators in Hepatocellular Carcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"Front Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic Transcriptomic M(6)A Decoration: Writers, Erasers, Readers and Functions in RNA Metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, Writing and Erasing mRNA Methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.632934","article-title":"RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma","volume":"11","author":"Pan","year":"2021","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10020-021-00415-y","article-title":"LncRNA HCG18 Upregulates TRAF4\/TRAF5 to Facilitate Proliferation, Migration and EMT of Epithelial Ovarian Cancer by Targeting miR-29a\/B","volume":"28","author":"Zhang","year":"2022","journal-title":"Mol Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12943-022-01539-3","article-title":"Long non-Coding RNA LINC00680 Functions as a ceRNA to Promote Esophageal Squamous Cell Carcinoma Progression Through the miR-423-5p\/PAK6 Axis","volume":"21","author":"Xue","year":"2022","journal-title":"Mol Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41419-022-04540-2","article-title":"The EMT-Induced lncRNA NR2F1-AS1 Positively Modulates NR2F1 Expression and Drives Gastric Cancer via miR-29a-3p\/VAMP7 Axis","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data With Deseq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: An R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene Set Variation Analysis for Microarray and RNA-Seq Data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","article-title":"WTAP Facilitates Progression of Hepatocellular Carcinoma via M6a-HuR-Dependent Epigenetic Silencing of ETS1","volume":"18","author":"Chen","year":"2019","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.578816","article-title":"IGF2BP2 Promotes Liver Cancer Growth Through an M6a-FEN1-Dependent Mechanism","volume":"10","author":"Pu","year":"2020","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1303-7","article-title":"YTHDF2 Promotes the Liver Cancer Stem Cell Phenotype and Cancer Metastasis by Regulating OCT4 Expression via M6a RNA Methylation","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene"},{"key":"B30","doi-asserted-by":"publisher","first-page":"22511","DOI":"10.1038\/s41598-021-02011-w","article-title":"Factor H-Related Protein 1 (FHR-1) Is Associated With Atherosclerotic Cardiovascular Disease","volume":"11","author":"Irmscher","year":"2021","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2021.05.015","article-title":"Beyond Factor H: The Impact of Genetic-Risk Variants for Age-Related Macular Degeneration on Circulating Factor-H-Like 1 and Factor-H-Related Protein Concentrations","volume":"108","author":"Cipriani","year":"2021","journal-title":"Am J Hum Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019040331","article-title":"Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes After Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome","volume":"30","author":"Zuber","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/jid.2013.346","article-title":"Complement Factor H: A Biomarker for Progression of Cutaneous Squamous Cell Carcinoma","volume":"134","author":"Riihila","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3390\/cancers13112709","article-title":"Prognostic Genetic Biomarkers Based on Oncogenic Signaling Pathways for Outcome Prediction in Patients With Oral Cavity Squamous Cell Carcinoma","volume":"13","author":"Fan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01893-4","article-title":"Vaccinia-Related Kinase 2 Drives Pancreatic Cancer Progression by Protecting Plk1 From Chfr-Mediated Degradation","volume":"40","author":"Zhu","year":"2021","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i27.3527","article-title":"Polo-Like Kinase 1, a New Therapeutic Target in Hepatocellular Carcinoma","volume":"18","author":"Mok","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/cancers12020491","article-title":"Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma","volume":"12","author":"Dimri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000340","article-title":"ATR Inhibitor AZD6738 Enhances the Antitumor Activity of Radiotherapy and Immune Checkpoint Inhibitors by Potentiating the Tumor Immune Microenvironment in Hepatocellular Carcinoma","volume":"8","author":"Sheng","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"119227","DOI":"10.1016\/j.lfs.2021.119227","article-title":"Identification of MCM Family as Potential Therapeutic and Prognostic Targets for Hepatocellular Carcinoma Based on Bioinformatics and Experiments","volume":"272","author":"Lei","year":"2021","journal-title":"Life Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41419-021-04418-9","article-title":"Matrix Stiffness Modulates Hepatic Stellate Cell Activation Into Tumor-Promoting Myofibroblasts via E2F3-Dependent Signaling and Regulates Malignant Progression","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.07.019","article-title":"Tumor Infiltrating Immune Cells in Gliomas and Meningiomas","volume":"53","author":"Domingues","year":"2016","journal-title":"Brain Behav Immun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0757","article-title":"Accumulation of Tumor-Infiltrating CD49a(+) NK Cells Correlates With Poor Prognosis for Human Hepatocellular Carcinoma","volume":"7","author":"Sun","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2007.04.005","article-title":"Differentiation and Function of Th17 T Cells","volume":"19","author":"Stockinger","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","article-title":"Late Developmental Plasticity in the T Helper 17 Lineage","volume":"30","author":"Lee","year":"2009","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753","article-title":"Reciprocal Developmental Pathways for the Generation of Pathogenic Effector TH17 and Regulatory T Cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cmet.2017.10.006","article-title":"CD38-NAD(+)Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response","volume":"27","author":"Chatterjee","year":"2018","journal-title":"Cell Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12935-022-02528-8","article-title":"The Role of Th17 Cells in the Pathogenesis and Treatment of Breast Cancer","volume":"22","author":"Karpisheh","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic Cells in Cancer Immunology and Immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/bs.ircmb.2019.07.008","article-title":"Interplay Between Dendritic Cells and Cancer Cells","volume":"348","author":"Martinek","year":"2019","journal-title":"Int Rev Cell Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5MR1216-508R","article-title":"Neutrophils as Active Regulators of the Immune System in the Tumor Microenvironment","volume":"102","author":"Shaul","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","article-title":"Engineering T Cells With Customized Therapeutic Response Programs Using Synthetic Notch Receptors","volume":"167","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/s41467-017-01015-3","article-title":"Single-Cell Mass Cytometry and Transcriptome Profiling Reveal the Impact of Graphene on Human Immune Cells","volume":"8","author":"Orecchioni","year":"2017","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60241-X","article-title":"Tumour Immunity: Effector Response to Tumour and Role of the Microenvironment","volume":"371","author":"Mantovani","year":"2008","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071702","article-title":"Ovarian Cancer-Associated Ascites Have High Proportions of Cytokine-Responsive CD56bright NK Cells","volume":"10","author":"Tonetti","year":"2021","journal-title":"Cells"},{"key":"B55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12985-022-01776-4","article-title":"Increased Expression of TIGIT and KLRG1 Correlates With Impaired CD56(bright) NK Cell Immunity in HPV16-Related Cervical Intraepithelial Neoplasia","volume":"19","author":"Nie","year":"2022","journal-title":"Virol J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14329","article-title":"Multidimensional Profiling Depicts Infiltrating Immune Cell Heterogeneity in the Tumor Microenvironment of Stage IA Non-Small Cell Lung Cancer","volume":"13","author":"Duan","year":"2022","journal-title":"Thorac Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.02.002","article-title":"Context-Dependent Regulation of Follicular Helper T Cell Survival","volume":"43","author":"Chen","year":"2022","journal-title":"Trends Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-022-00693-5","article-title":"The Link Between Circulating Follicular Helper T Cells and Autoimmunity","volume":"11","author":"Walker","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1168556","DOI":"10.1080\/2162402X.2016.1168556","article-title":"The Immune Network in Thyroid Cancer","volume":"5","author":"Galdiero","year":"2016","journal-title":"Oncoimmunology"},{"key":"B60","article-title":"T Lymphocytes in Hepatocellular Carcinoma Immune Microenvironment: Insights Into Human Immunology and Immunotherapy","volume":"10","author":"Bian","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","article-title":"RNA N(6)-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the M(6)A-GLUT1-Mtorc1 Axis and Is a Therapeutic Target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41419-020-02967-z","article-title":"LIN28B-AS1-IGF2BP1 Binding Promotes Hepatocellular Carcinoma Cell Progression","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e3134","DOI":"10.1002\/jgm.3134","article-title":"LINC00467 Promotes Cell Proliferation and Metastasis by Binding With IGF2BP3 to Enhance the mRNA Stability of TRAF5 in Hepatocellular Carcinoma","volume":"22","author":"Jiang","year":"2020","journal-title":"J Gene Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31766","article-title":"Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism","volume":"74","author":"Su","year":"2021","journal-title":"Hepatology"},{"key":"B65","article-title":"RBMX Contributes to Hepatocellular Carcinoma Progression and Sorafenib Resistance by Specifically Binding and Stabilizing BLACAT1","volume":"10","author":"Song","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41420-021-00703-w","article-title":"RBM15 Promotes Hepatocellular Carcinoma Progression by Regulating N6-Methyladenosine Modification of YES1 mRNA in an IGF2BP1-Dependent Manner","volume":"7","author":"Cai","year":"2021","journal-title":"Cell Death Discov"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29683","article-title":"RNA N6-Methyladenosine Methyltransferase-Like 3 Promotes Liver Cancer Progression Through YTHDF2-Dependent Posttranscriptional Silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.892750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T05:56:42Z","timestamp":1655877402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.892750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2022.892750"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.892750","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"article-number":"892750"}}